ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,921Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 978

$935K Total Retail Price of All Prescriptions

Rank: 8 out of 978

501 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 501 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 501 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 18,774 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,261 1,105 1 11
SIMVASTATIN 781 686 2 2
FUROSEMIDE 773 738 3 9
AMLODIPINE BESYLATE 751 699 4 6
LEVOTHYROXINE SODIUM 681 614 5 4
LISINOPRIL 632 548 6 1
METOPROLOL TARTRATE 613 574 7 10
POTASSIUM CHLORIDE 459 447 8 41
CITALOPRAM HBR 452 431 9 14
ATENOLOL 445 409 10 8
OMEPRAZOLE 437 355 11 3
DONEPEZIL HCL 409 409 12 26
MIRTAZAPINE 390 374 13 31
TRAZODONE HCL 355 337 14 18
HYDROCHLOROTHIAZIDE 321 291 15 5
NAMENDA 269 269 16 45
METOPROLOL SUCCINATE 265 255 17 13
METFORMIN HCL 261 216 18 7
GABAPENTIN 257 223 19 15
PRAVASTATIN SODIUM 237 237 20 16
ALENDRONATE SODIUM 224 224 21 20
SERTRALINE HCL 207 200 22 21
RISPERIDONE 206 199 23 49
CIPROFLOXACIN HCL 194 176 24 105
PREDNISONE 192 187 25 47
TRAMADOL HCL 188 179 26 24
ATORVASTATIN CALCIUM 186 168 27 12
DIGOXIN 162 154 28 54
GLYBURIDE 160 148 R 29 44
CLOPIDOGREL 152 140 30 61
DIVALPROEX SODIUM 148 109 31 56
HYDROCODONE-ACETAMINOPHEN 145 119 S3 32 17
PANTOPRAZOLE SODIUM 145 131 32 39
CARVEDILOL 143 132 34 55
CRESTOR 135 123 35 30
QUETIAPINE FUMARATE 130 121 36 51
NIFEDIPINE ER 129 88 37 70
FLUTICASONE PROPIONATE 127 102 38 28
IPRATROPIUM-ALBUTEROL 125 125 39 101
DIOVAN 123 123 40 43
ALLOPURINOL 123 111 40 34
PAROXETINE HCL 122 118 42 52
OXYCODONE-ACETAMINOPHEN 121 71 S2 43 25
ZOLPIDEM TARTRATE 121 92 43 32
ESCITALOPRAM OXALATE 121 111 43 117
LEVETIRACETAM 119 113 46 93
ISOSORBIDE MONONITRATE ER 117 105 47 57
LANTUS 116 100 48 40
SPIRIVA 112 97 49 37
GLIPIZIDE 102 102 50 50
VENLAFAXINE HCL ER 102 102 50 86
CARBIDOPA-LEVODOPA 101 95 52 81
NYSTATIN 96 89 53 126
LIDODERM 92 92 54 65
PROAIR HFA 89 48 55 19
OLANZAPINE 88 88 56 75
NITROFURANTOIN 87 73 57 211
LEVOFLOXACIN 83 72 58 98
TRIAMTERENE-HCTZ 82 82 59 67
LATANOPROST 81 81 60 163
PLAVIX 80 71 61 96
ALBUTEROL SULFATE 78 73 62 132
FAMOTIDINE 77 69 63 107
HYDRALAZINE HCL 75 64 64 139
METHADONE HCL 74 11 S2 65 107
NOVOLOG 74 68 65 121
ADVAIR DISKUS 72 58 67 35
OXYBUTYNIN CHLORIDE 71 43 68 141
OXYCONTIN 70 59 S2 69 79
FLOVENT HFA 64 54 70 91
FENTANYL 61 49 S2 71 85
KLOR-CON M20 61 51 71 66
IBUPROFEN 59 27 73 38
RAMIPRIL 54 54 74 204
HYDROCORTISONE 53 51 75 255
TAMSULOSIN HCL 53 43 75 33
BUPROPION HCL 52 40 77 332
LACTULOSE 52 51 77 92
PROPRANOLOL HCL 52 52 77 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 15, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.